BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11244021)

  • 1. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Hypertension; 2001 Mar; 37(3):936-42. PubMed ID: 11244021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin.
    Kuo JJ; Jones OB; Hall JE
    Hypertension; 2001 Feb; 37(2 Pt 2):670-6. PubMed ID: 11230354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats.
    Overton JM; Williams TD; Chambers JB; Rashotte ME
    Hypertension; 2001 Feb; 37(2 Pt 2):663-9. PubMed ID: 11230353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term physiological hyperleptinemia decreases arterial blood pressure.
    Knight WD; Seth R; Boron J; Overton JM
    Regul Pept; 2009 Apr; 154(1-3):60-8. PubMed ID: 19323984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic consequences of neuropeptide Y-induced obesity.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):137-42. PubMed ID: 11865825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide.
    Tallam LS; Kuo JJ; da Silva AA; Hall JE
    Hypertension; 2004 Dec; 44(6):853-8. PubMed ID: 15545513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
    Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
    Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.
    da Silva AA; Kuo JJ; Hall JE
    Hypertension; 2004 Jun; 43(6):1312-7. PubMed ID: 15123576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?
    Mitchell JL; Morgan DA; Correia ML; Mark AL; Sivitz WI; Haynes WG
    Hypertension; 2001 Nov; 38(5):1081-6. PubMed ID: 11711501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic leptin infusion increases arterial pressure.
    Shek EW; Brands MW; Hall JE
    Hypertension; 1998 Jan; 31(1 Pt 2):409-14. PubMed ID: 9453337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic CNS-mediated cardiometabolic actions of leptin: potential role of sex differences.
    da Silva AA; Pinkerton MA; Spradley FT; Palei AC; Hall JE; do Carmo JM
    Am J Physiol Regul Integr Comp Physiol; 2021 Feb; 320(2):R173-R181. PubMed ID: 33206555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals.
    Small CJ; Kim MS; Stanley SA; Mitchell JR; Murphy K; Morgan DG; Ghatei MA; Bloom SR
    Diabetes; 2001 Feb; 50(2):248-54. PubMed ID: 11272133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin.
    Rahmouni K; Morgan DA
    Hypertension; 2007 Mar; 49(3):647-52. PubMed ID: 17190874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of central leptin infusion on the reward-potentiating effect of D-amphetamine.
    Hao J; Cabeza de Vaca S; Pan Y; Carr KD
    Brain Res; 2006 May; 1087(1):123-33. PubMed ID: 16600190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin.
    da Silva AA; do Carmo JM; Freeman JN; Tallam LS; Hall JE
    Diabetes; 2009 Aug; 58(8):1749-56. PubMed ID: 19491210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of central angiotensin II on body weight gain in young rats.
    Porter JP; Anderson JM; Robison RJ; Phillips AC
    Brain Res; 2003 Jan; 959(1):20-8. PubMed ID: 12480154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Antidiabetic Actions of Leptin: Evidence From Parabiosis Studies for a CNS-Derived Circulating Antidiabetic Factor.
    da Silva AA; Hall JE; Dai X; Wang Z; Salgado MC; do Carmo JM
    Diabetes; 2021 Oct; 70(10):2264-2274. PubMed ID: 34344788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal neurogenic mediation of intracerebroventricular angiotensin II hypertension in rats raised on high sodium chloride diet.
    Osborn JL; Camara AK
    Hypertension; 1997 Sep; 30(3 Pt 1):331-6. PubMed ID: 9314413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion.
    Matson CA; Reid DF; Ritter RC
    Am J Physiol Regul Integr Comp Physiol; 2002 May; 282(5):R1368-73. PubMed ID: 11959678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous lumbar intrathecal infusion of leptin in rats on weight regulation.
    Yaksh TL; Scott B; LeBel CL
    Neuroscience; 2002; 110(4):703-10. PubMed ID: 11934477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.